✦ LIBER ✦

A Systematic Review of Economic Evidence in Hepatitis C: An Overview of Cost, Utility and Cost-Effectiveness Data

✍ Scribed by Woods, M.S.; Kiri, S.; Ling, C.; McCrink, L.; Zimovetz, E.; Hass, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN29 EFFECTIVENESS AND COST-EFFECTIVENE

✍ G Sroczynski; E Esteban; A Conrads-Frank; R Schwarzer; N Mühlberger; DR Wright; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Comparative cost-effectiveness of antivi

✍ Xin Sun; Wen-Xia Qin; You-Ping Li; Xu-Hua Jiang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

When is Cancer Care Cost-Effective? A Sy

✍ Greenberg, D.; Earle, C.; Fang, C.-H.; Eldar-Lissai, A.; Neumann, P. J. 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 153 KB

CN2 WHEN IS CANCER CARE COST-EFFECTIVE?

✍ D Greenberg; C Earle; C Fang; A Eldar-Lissai; PJ Neumann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

A Systematic Review Of Cost-Utility Anal

✍ Zhong, Y.; Lin, P.J.; Winn, A.; Cohen, J.T; Neumann, P.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-of-illness studies and cost-effecti

✍ Alexander Konnopka; Falk Leichsenring; Eric Leibing; Hans-Helmut König 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 347 KB